ARS PHARMACEUTICALS INC

Ticker: SPRY CUSIP: 82835W108 Class: Common Stock

ROYCE & ASSOCIATES LP's Holding History (CIK: 0000906304)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 207,051 Value ($000) $2,412 Avg Close $9.72 Range $6.66 - $11.99
Q2 2025
Shares 256,269 Value ($000) $4,472 Avg Close $14.43 Range $11.65 - $18.90
Q1 2025
Shares 642,766 Value ($000) $8,086 Avg Close $12.03 Range $10.00 - $15.19
Q4 2024
Shares 929,613 Value ($000) $9,807 Avg Close $14.01 Range $10.20 - $18.51
Q3 2024
Shares 691,455 Value ($000) $10,026 Avg Close $11.89 Range $8.35 - $16.50
Q2 2024
Shares 645,700 Value ($000) $5,495 Avg Close $8.87 Range $7.55 - $10.22
Q1 2024
Shares 558,700 Value ($000) $5,710 Avg Close $7.46 Range $5.19 - $11.27
Q4 2023
Shares 473,700 Value ($000) $2,596 Avg Close $4.38 Range $3.35 - $5.79
Q3 2023
Shares 463,700 Value ($000) $1,753 Avg Close $6.56 Range $2.55 - $8.00
Q2 2023
Shares 463,700 Value ($000) $3,107 Avg Close $6.64 Range $3.99 - $9.65
Q1 2023
Shares 303,900 Value ($000) $1,978 Avg Close $7.68 Range $5.97 - $9.23